CN Patent

CN101217983A — 生产放射性气溶胶的改进方法

Assigned to VITA MEDICAL AUSTRALIA Pty Ltd · Expires 2008-07-09 · 18y expired

What this patent protects

一种用于形成适合用于患者医疗诊断的可吸入同位素化合物，该方法包括下列步骤：(a)石墨坩埚电解装载同位素；(b)升华所述坩埚中的任何同位素载体；(c)烧蚀石墨坩埚中的所述同位素，形成烧蚀气溶胶；(d)直接将所述气溶胶递送给患者即时使用。该同位素包括锝。

USPTO Abstract

一种用于形成适合用于患者医疗诊断的可吸入同位素化合物，该方法包括下列步骤：(a)石墨坩埚电解装载同位素；(b)升华所述坩埚中的任何同位素载体；(c)烧蚀石墨坩埚中的所述同位素，形成烧蚀气溶胶；(d)直接将所述气溶胶递送给患者即时使用。该同位素包括锝。

Drugs covered by this patent

technetium-tc-99m-labeled-carbon (TECHNETIUM TC-99M LABELED CARBON)

Patent Metadata

Patent number: CN101217983A
Jurisdiction: CN
Classification: —
Expires: 2008-07-09
Drug substance claim: No
Drug product claim: No
Assignee: VITA MEDICAL AUSTRALIA Pty Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.